Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Tzer-Ming Chuang"'
Autor:
Shih-Feng Cho, Tsung-Jang Yeh, Hui-Ching Wang, Jeng-Shiun Du, Yuh-Ching Gau, Yu-Yin Lin, Tzer-Ming Chuang, Yi-Chang Liu, Hui-Hua Hsiao, Sin-Hua Moi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The present study aimed to elucidate the prognostic mutation signature (PMS) associated with long-term survival in a diffuse large B-cell lymphoma (DLBCL) cohort. All data including derivation and validation cohorts were retrospectively retr
Externí odkaz:
https://doaj.org/article/01981a3d3977420b94a7b8a4709014ae
Autor:
Hui-Hua Hsiao, Yi-Chang Liu, Hui-Ching Wang, Jeng-Shiun Du, Shih-Hao Tang, Tsung-Jang Yeh, Chieh-Yu Hsieh, Yuh-Ching Gau, Ya-Lun Ke, Tzer-Ming Chuang, Chi-En Hsiao, Chia-Hung Yen, Shih-Feng Cho, Samuel Yien Hsiao, Shyh-Shin Chiou, Shang-Yi Lin, Chin-Mu Hsu, Po-Liang Lu
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 10, Pp 2123-2129 (2022)
Purpose: To compare a lateral-flow device (LFD) method to the galactomannan assay (GM) for the diagnosis of invasive aspergillosis (IA). Methods: First, 20 GM-positive serum samples stored for two years were retested with both the GM and LFD assays.
Externí odkaz:
https://doaj.org/article/a3e40b76e1bb4805a121de391aa2d527
Autor:
Tsung-Jang Yeh, Hui-Ching Wang, Shih-Feng Cho, Chun-Chieh Wu, Tzu-Yu Hsieh, Chien-Tzu Huang, Min-Hong Wang, Tzer-Ming Chuang, Yuh-Ching Gau, Jeng-Shiun Du, Yi-Chang Liu, Hui-Hua Hsiao, Mei-Ren Pan, Li-Tzong Chen, Sin-Hua Moi
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3113 (2023)
The treatment of head and neck squamous cell carcinomas (HNSCCs) is multimodal, and chemoradiotherapy (CRT) is a critical component. However, the availability of predictive or prognostic markers in patients with HNSCC is limited. Inflammation is a we
Externí odkaz:
https://doaj.org/article/f0a20da5a3e54076b20fa93c8e8244b6
Autor:
Hui‐Hua Hsiao, Chi‐Jung Yeh, Shuo‐Chun Ting, Tzer‐Ming Chuang, Ya‐Lun Ke, Tsung‐Jang Yeh, Yu‐Chin Gau, Jeng‐Shiun Du, Chi‐En Hsiao, Hui‐Ching Wang, Shih‐Feng Cho, Chin‐Mu Hsu, Yi‐Chang Liu
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 38, Iss 1, Pp 65-69 (2022)
Abstract Identification of alloantibodies and achieving a reduction in the rate of red blood cell (RBC) alloimmunization are important issues to prevent transfusion complications. The aim of this study was to identify the antigen and alloantibodies i
Externí odkaz:
https://doaj.org/article/25f4a920f97948769e96c328963f955c
Autor:
Tsung-Jang Yeh, Chi-Wen Luo, Jeng-Shiun Du, Chien-Tzu Huang, Min-Hung Wang, Tzer-Ming Chuang, Yuh-Ching Gau, Shih-Feng Cho, Yi-Chang Liu, Hui-Hua Hsiao, Li-Tzong Chen, Mei-Ren Pan, Hui-Ching Wang, Sin-Hua Moi
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 691 (2023)
Head and neck cancers (HNCs) are among the ten leading malignancies worldwide. Despite significant progress in all therapeutic modalities, predictive biomarkers, and targeted therapies for HNCs are limited and the survival rate is unsatisfactory. The
Externí odkaz:
https://doaj.org/article/4ed27ffb8415412c8bc1882fbbe58848
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 4, Pp 1155-1157 (2021)
Externí odkaz:
https://doaj.org/article/8f4d7b79acd1438db786de3a985f8a02
Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and Autophagy
Autor:
Chin-Mu Hsu, Chia-Hung Yen, Shu-Chen Wang, Yi-Chang Liu, Chien-Tzu Huang, Min-Hong Wang, Tzer-Ming Chuang, Ya-Lun Ke, Tsung-Jang Yeh, Yuh-Ching Gau, Jeng-Shiun Du, Hui-Ching Wang, Shih-Feng Cho, Yuhsin Tsai, Chi-En Hsiao, Samuel Yien Hsiao, Hui-Hua Hsiao
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1638 (2022)
Background: Carfilzomib, the proteasome inhibitor, can increase the overall survival rate of multiple myeloma (MM) patients undergoing targeted therapy. However, relapse and toxicity present great challenges for such treatment, so an urgent need for
Externí odkaz:
https://doaj.org/article/0f2745e4877347619b199b1a464e9aa2
Autor:
Tsung-Jang Yeh, Ching-I Yang, Chien-Tzu Huang, Min-Hung Wang, Tzer-Ming Chuang, Ya-Lun Ke, Yuh-Ching Gau, Jeng-Shiun Du, Hui-Ching Wang, Shih-Feng Cho, Ching-Ping Lee, Chin-Mu Hsu, Hui-Hua Hsiao, Yi-Chang Liu
Publikováno v:
Journal of Fungi, Vol 8, Iss 4, p 408 (2022)
Infection is a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT) especially cytomegalovirus (CMV) infection and invasive fungal infection (IFI). Taiwan is a high CMV seroprevalence area. Our study aimed to evalua
Externí odkaz:
https://doaj.org/article/003db7381b2f464faff04590929f2e4a
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 4, Pp 1155-1157 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b70553de2f10c31f1253c3523156a5b
http://www.sciencedirect.com/science/article/pii/S0929664620304691
http://www.sciencedirect.com/science/article/pii/S0929664620304691
Autor:
Jeng-Shiun Du, Yi-Chun Kuo, Hon-Yi Shi, Ming-Chung Wang, Li-Ying Wang, Tzer-Ming Chuang, Ya-Lun Ke, Tsung-Jang Yeh, Yu-Ching Gau, Hui-Ching Wang, Shih-Feng Cho, Samuel Yien Hsiao, Yi-Chang Liu, Chin-Mu Hsu, Hui-Hua Hsiao
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 2; Pages: 130
Background: This study aimed to evaluate the cost-effectiveness of treating transplant-ineligible myeloma patients with either a bortezomib plus thalidomide plus dexamethasone (VTD) or a bortezomib plus melphalan plus prednisolone (VMP) treatment in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eb4b29e685982999bbe6afdd6c0e761
https://pubmed.ncbi.nlm.nih.gov/35207619
https://pubmed.ncbi.nlm.nih.gov/35207619